Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/19/2024 | $5.30 | Reduce → Hold | HSBC Securities | |
| 11/19/2024 | Buy → Hold | Needham | ||
| 11/14/2024 | $3.00 → $2.00 | Buy → Neutral | UBS | |
| 11/11/2024 | Buy → Neutral | UBS | ||
| 10/21/2024 | Neutral → Underweight | JP Morgan | ||
| 9/30/2024 | Neutral | JP Morgan | ||
| 9/19/2024 | $3.00 | Underweight | Barclays | |
| 9/13/2024 | $6.50 | Neutral → Buy | Colliers Securities |
4 - QuantumScape Corp (0001811414) (Issuer)
4 - QuantumScape Corp (0001811414) (Issuer)
4 - QuantumScape Corp (0001811414) (Issuer)
144 - QuantumScape Corp (0001811414) (Subject)
144 - fuboTV Inc. /FL (0001484769) (Subject)
8-K - NOVAVAX INC (0001000694) (Filer)
SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)
SC 13G/A - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)
SC 13G/A - Leslie's, Inc. (0001821806) (Subject)
Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.08 per share of common stock to be paid on January 9, 2025, to stockholders of record on December 12, 2024. About Medical Properties Trust, Inc. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 402 facilities and approximately 40,000 licensed beds in nine countries and across three continents as of September
Helping pets get the care they need, Trupanion surpasses $3 billion in payments to veterinarians and pet parents. Data shows allergies as top condition affecting dogs and cats. SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Pet medical insurance provider Trupanion would like to thank a 9-year-old Maltipoo from Coral Springs, Florida named Lexi for helping the Seattle based company achieve a major milestone. Trupanion (NASDAQ:TRUP) has now paid over $3 billion in medical bills to veterinarians and pet parents. The massive number shows just how passionate Trupanion is about protecting pets and providing pet parents worldwide with financial peace of mind. "Trupanion exists to help
SAN FRANCISCO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ:BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today announced that Joe Vernachio, CEO, and Annie Mitchell, CFO, will be participating in the Morgan Stanley Global Consumer & Retail Conference on Wednesday, December 4, 2024 in New York City. About Allbirds, Inc. Based in San Francisco, with its roots in New Zealand, Allbirds launched in 2016 with a single shoe: the now iconic Wool Runner. In the years since, Allbirds has sold millions of pairs of shoes, and has maintained its commitment to incredible comfort, versatile style and unmatched quality. Th
HSBC Securities upgraded QuantumScape Corporation from Reduce to Hold and set a new price target of $5.30
Needham downgraded Blink Charging from Buy to Hold
UBS downgraded Blink Charging from Buy to Neutral and set a new price target of $2.00 from $3.00 previously
Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE:MPW) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.08 per share of common stock to be paid on January 9, 2025, to stockholders of record on December 12, 2024. About Medical Properties Trust, Inc. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 402 facilities and approximately 40,000 licensed beds in nine countries and across three continents as of September
PHOENIX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, today announced that its financial results for the fourth quarter and full year of fiscal 2024 will be released after market close on Monday, November 25, 2024. The Company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial 877-407-0784 (international callers please dial 1-201-689-8560) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available o
U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidatesAchieved total revenue of $85 million in the third quarter of 2024 Ended the third quarter of 2024 with $1 billion in cash and receivablesReceived authorization from U.S. FDA and European Commission for updated 2024-2025 formula COVID-19 vaccine in individuals aged 12 and olderOutlined R&D strategy based on its proven technology platformUpdates full year 2024 financial guidanceCompany to host conference call today at 8:30 a.m. ETGAITHERSBURG, Md., Nov. 12, 2024 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-base
FuboTV Inc. (d/b/a Fubo) (NYSE:FUBO), the leading sports-first live TV streaming platform, today announced that on September 27, 2024, the Compensation Committee of Fubo's Board of Directors granted restricted stock unit awards covering an aggregate of 75,512 shares of its common stock to eight new employees to induce them to join Fubo. The awards were granted under Fubo's 2024 Employment Inducement Equity Incentive Plan, and vest annually over a four-year period following their grant, subject to continued employment. The awards were granted as employment inducement awards pursuant to the New York Stock Exchange rules. About Fubo With a global mission to aggregate the best in TV, includin
OKLAHOMA CITY, Oct. 1, 2024 /PRNewswire/ -- SandRidge Energy, Inc. (the "Company" or "SandRidge") (NYSE:SD) today announced changes to the Board and Management that will further position the Company to execute on its strategy. Vincent ("Vince") Intrieri has been appointed by the Board, by recommendation of the Nominating and Governance Committee, as Chairman effective October 1, 2024. Mr. Intrieri is the Founder and CEO of VDA Capital Management LLC, a private investment fund founded in 2017. Mr. Intrieri was previously employed by Carl C. Icahn-related entities in various inv
Ruxandra Draghia-Akli, MD, PhD brings more than 20 years of extensive clinical, corporate and global public health expertise to support Novavax's transition to an R&D-focused organizationDr. Draghia-Akli will be integral in strategically evaluating the Company's pipeline and opportunities for its Matrix-M™ adjuvant and protein-based technology platformGAITHERSBURG, Md., Sept. 25, 2024 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Ruxandra Draghia-Akli, MD, PhD, will join the Company in November 2024 as Executive Vice President and Head of Research & Development (R&D). Dr. Draghia-Akli brings m
For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons
For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of
For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO
U.S. stock futures were lower this morning, with the Nasdaq futures dipping around 0.5% on Thursday. Shares of Ford Motor Company (NYSE:F) fell sharply in today's pre-market trading following a second-quarter earnings miss. Ford reported second-quarter revenue of $47.8 billion, up 6% year-over-year. The revenue beat a Street consensus estimate of $44 billion according to data from Benzinga Pro. The company reported quarterly earnings per share of 47 cents, missing a Street consensus estimate of 68 cents. Ford Motor shares dipped 13% to $11.90 in the pre-market trading session. Here are some big stocks recording losses in today's pre-market trading session. Edwards Lifescience
QuantumScape Corporation (NYSE:QS) reported its second-quarter financial results Wednesday. Here's a look at the details: The Details: QuantumScape reported GAAP quarterly losses of 25 cents per share which missed the analyst consensus estimate of losses of 23 cents by 8.7%. The company reported capital expenditures in the second quarter were $18.9 million and primarily supported equipmentpurchases for low-volume QSE-5 prototype production, as well as the Cobra process and other equipment as the company prepares for higher-volume QSE-5 prototype production in 2025. QuantumScape ended the second quarter with $938 million in liquidity. The company said its recent licensing deal w
4 - Allbirds, Inc. (0001653909) (Issuer)
4 - Blink Charging Co. (0001429764) (Issuer)
4 - MEDICAL PROPERTIES TRUST INC (0001287865) (Issuer)
